Nurix Therapeutics, Inc. NRIX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s invested capital?
- Nurix Therapeutics, Inc. (NRIX) reported invested capital of $467.39M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s invested capital changed year-over-year?
- Nurix Therapeutics, Inc.'s invested capital increased by 8.5% year-over-year, from $430.72M to $467.39M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s invested capital has grown at a 13.4% compound annual growth rate (CAGR), from $185.16M to $346.55M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).